BWCGF yields 2380.95% · JNJ yields 2.13%● Live data
📍 BWCGF pulled ahead of the other in Year 1
Combined, BWCGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BWCGF + JNJ for your $10,000?
Blackwolf Copper and Gold Ltd., together with its subsidiaries, engages in the acquisition, exploration, and development of mineral properties. It explores for copper, gold, zinc, and silver deposits. The company holds a 100% interest in the Niblack Project, which consists of an area of approximately 6,200 acres located on Prince of Wales Island in Southeast Alaska, the United States; and Hyder Properties that consists of Texas Creek, Cantoo, and Casey properties covering an area of 3,863 hectares situated in Southeast Alaska, the United States. It also holds a 100% interest in the Mineral Hill gold, silver, and polymetallic property that comprises of 60 claims covering an area of 502 hectares located in Golden Triangle, Alaska. The company was formerly known as Heatherdale Resources Ltd. and changed its name to Blackwolf Copper and Gold Ltd. in April 2021. Blackwolf Copper and Gold Ltd. was incorporated in 2007 and is based in Vancouver, Canada.
Full BWCGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.